ctDNA-Based Detection of Residual Disease Prognostic for Resected CRC
ctDNA-based detection of molecular residual disease in response to adjuvant chemotherapy prognostic of outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.